← Back to Search

Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents (CAMP Trial)

N/A
Waitlist Available
Led By Daniel Hsia, PhD
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 8
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions

Summary

The purpose of this study is to determine whether taking a combination of caffeine and albuterol three times per day will increase muscle and decrease fat in your child's body and to determine how these medications make your child feel. Albuterol is approved by the FDA for the treatment of asthma. It is not approved to increase muscle and decrease body fat in children.

Eligible Conditions
  • Obesity
  • Childhood Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Fat Mass With Caffeine/Albuterol
Change in Lean Mass With Caffeine/Albuterol

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Caffeine 100mg / Albuterol 4mgExperimental Treatment2 Interventions
One capsule 3 times per day orally for a total of 8 weeks and family weight management counseling for a total of 8 weeks.
Group II: PlaceboPlacebo Group2 Interventions
One capsule 3 times per day orally for a total of 8 weeks and family weight management counseling for a total of 8 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Salbutamol
FDA approved
Family weight management counseling
2016
N/A
~20

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
309 Previous Clinical Trials
179,880 Total Patients Enrolled
68 Trials studying Obesity
118,370 Patients Enrolled for Obesity
Leverage Innovation for Technology Transfer Fund (LSU LIFT2)UNKNOWN
Daniel Hsia, PhDPrincipal InvestigatorPennington Biomedical Research Center
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top